|
⚲
|
| Keyboard |
| van der Horst Edward
✚
|
|
|---|---|
| CIK # | 0001957499 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001957499] | |
| 4 | [0001957499] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Faeth Therapeutics Inc | |
| van der Horst Edward |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2025-02-19 | Tax withheld | 2,276 | $0.48 | 1,092 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 110,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-12-20 | Grant | 100,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 125,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2024-02-15 | Tax withheld | 2,843 | $0.79 | 2,246 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 90,102 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 17,700 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Tax withheld | 9,525 | $1.50 | 14,288 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2023-02-15 | Grant | 75,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 23,565 | $0.00 |